# Expression and Role of the JAK/STAT Pathway in Sarcoidosis Granuloma Cells

> **NCT04751279** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 80 (estimated)

## Conditions studied

- Sarcoidosis
- JAK-STAT Pathway Deregulation

## Interventions

- **OTHER:** Blood sample

## Key facts

- **NCT ID:** NCT04751279
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-09
- **Primary completion:** 2024-01-01
- **Final completion:** 2024-01-02
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04751279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04751279, "Expression and Role of the JAK/STAT Pathway in Sarcoidosis Granuloma Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04751279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*